Newly published research from a National Cancer Institute-funded randomized trial shows that women who were provided with skills to manage stress early in their breast cancer treatment show greater length of survival and ...
Dec 1, 2015
0
2
Based on the results of EORTC trial 18071, the FDA expanded the approval of Yervoy (ipilimumab) in melanoma to include adjuvant treatment of patients with stage 3 melanoma at high risk of recurrence following complete resection.
Nov 13, 2015
0
4
Oropharyngeal cancer patients who were found to have detectable traces of human papillomavirus type 16 (HPV16) in their saliva following cancer treatment are at an increased risk for recurrence, a study led by researchers ...
Jul 30, 2015
0
21
Results of an EORTC trial appearing in The Lancet Oncology show that adjuvant Ipilimumab significantly improves recurrence-free survival in patients with completely resected stage III melanoma at high risk of disease recurrence, ...
Apr 20, 2015
0
3
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Apr 15, 2015
0
16
Measurement of circulating tumor DNA (ctDNA) in blood can be used to detect disease recurrence in patients with a curable form of cancer known as diffuse large B-cell lymphoma (DLBCL). In most patients, measurement of ctDNA ...
Apr 3, 2015
0
12
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was ...
Feb 24, 2015
0
5
UCLA transplantation researchers have developed a novel method that more accurately calculates the risk of disease recurrence in liver cancer patients who have undergone a liver transplant, providing a new tool to help physicians ...
Jan 13, 2015
0
38
Higher levels of total cholesterol and triglycerides, two types of fat, in the blood of men who underwent surgery for prostate cancer, were associated with increased risk for disease recurrence, according to a study published ...
Oct 10, 2014
0
0
A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a powerful ...
Sep 5, 2014
0
0
